(Circulation. 1995;91:1545-1551.)
© 1995 American Heart Association, Inc.
Articles |
Inhibition of Nitric Oxide Synthesis Reduces Infarct Size by an Adenosine-Dependent Mechanism
From the Department of Nephrology (R.G.W., G.H.N.), Institute of Urology and Nephrology; and The Hatter Institute for Cardiovascular Studies (V.C.P., D.M.Y.), Department of Academic Cardiology, University College London Medical School, London, UK.
Correspondence to Professor D.M. Yellon, The Hatter Institute for Cardiovascular Studies, Department of Academic Cardiology, University College London Medical School, Gower St, London, UK WC1E 6AU.
Background Nitric oxide (NO) is both a potent endogenous vasodilator with potential to attenuate ischemia-reperfusion injury and a mediator of tissue injury. The aim of the present study was to investigate the mechanism by which prior inhibition of NO synthesis can lessen ischemia-reperfusion injury in the isolated rabbit heart.
Methods and Results We examined the effects of inhibition of NO synthesis on infarct size using a model of coronary artery ligation in isolated rabbit hearts perfused at a constant flow rate of 35 mL/min. Infarct size averaged 65% of the zone at risk after 45 minutes of ischemia and 180 minutes of reperfusion. The addition of 30 µmol/L NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthesis, to the perfusate reduced the infarct-to-risk (I/R) ratio to an average of 41% (P<.05 versus control). This effect was abolished by pretreatment with 75.5 µmol/L 8-p-sulfophenyl theophylline (SPT), an adenosine receptor antagonist (I/R ratio, 63%). Ischemic preconditioning (5 minutes of ischemia and 10 minutes of reperfusion) before 45 minutes of ischemia and 3 hours of reperfusion reduced the I/R ratio to an average of 21%, and this was not augmented by pretreatment with L-NAME (I/R ratio, 20%). However, all protection due to preconditioning and L-NAME was lost in hearts pretreated with SPT (I/R ratio, 59%). In a separate set of experiments, adenosine concentration in the coronary perfusate and myocardial lactate concentrations were measured. Treatment with L-NAME increased the average adenosine concentration in the perfusate from 5.7 µmol/L per 100 g of heart (control) to a peak of 24.0 µmol/L per 100 g of heart; however, there was no effect on average myocardial lactate concentration (control, 4.6 µmol/g dry wt; L-NAME, 5.5 µmol/g dry wt). In contrast, after 5 minutes of global ischemia, the average adenosine concentration peaked at 139.0 µmol/L per 100 g of heart, and the average myocardial lactate concentration increased to 27.1 µmol/g dry wt.
Conclusions Infarct size limitation after inhibition of NO synthesis shares a common mechanism with that of ischemic preconditioning and is dependent on the release of adenosine. However, in this model, adenosine release after inhibition of NO synthesis is not secondary to myocardial ischemia. The protection of the heart against ischemic injury by adenosine appears to be concentration dependent.
Key Words: nitric oxide • adenosine • reperfusion • ischemia
This article has been cited by other articles:
 |
|
 |
|
  P. H. McNulty, S. Scott, V. Kehoe, M. Kozak, L. I. Sinoway, and J. Li Nitrite consumption in ischemic rat heart catalyzed by distinct blood-borne and tissue factors Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2143 - H2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ramachandran, S. Jha, and D. J. Lefer REVIEW Paper: Pathophysiology of Myocardial Reperfusion Injury: The Role of Genetically Engineered Mouse Models Vet. Pathol., September 1, 2008; 45(5): 698 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Cohen, X.-M. Yang, and J. M. Downey Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies Cardiovasc Res, May 1, 2006; 70(2): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gamboa, R. Abraham, A. Diedrich, C. Shibao, S. Y. Paranjape, G. Farley, and I. Biaggioni Role of Adenosine and Nitric Oxide on the Mechanisms of Action of Dipyridamole Stroke, October 1, 2005; 36(10): 2170 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, C. Yin, L. Xi, and R. C. Kukreja Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2070 - H2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Qin, X.-M. Yang, L. Cui, S. D. Critz, M. V. Cohen, N. C. Browner, T. M. Lincoln, and J. M. Downey Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H712 - H718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schulz, M. Kelm, and G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 402 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Galinanes and A. G Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res, February 15, 2004; 61(3): 512 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Peart and J. P Headrick Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects Cardiovasc Res, June 1, 2003; 58(3): 589 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lebuffe, P. T. Schumacker, Z.-H. Shao, T. Anderson, H. Iwase, and T. L. Vanden Hoek ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H299 - H308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J, March 1, 2002; 16(3): 327 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R Cross, E. Murphy, W. J Koch, and C. Steenbergen Male and female mice overexpressing the {beta}2-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide Cardiovasc Res, February 15, 2002; 53(3): 662 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M Bell and D. M Yellon The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice Cardiovasc Res, November 1, 2001; 52(2): 274 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R D Rakhit and M S Marber Nitric oxide: an emerging role in cardioprotection? Heart, October 1, 2001; 86(4): 368 - 372. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Costa, N. J. Christensen, G. Farley, and I. Biaggioni NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1494 - R1498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Rossoni, B. Manfredi, V. D. G. Colonna, M. Bernareggi, and F. Berti The Nitroderivative of Aspirin, NCX 4016, Reduces Infarct Size Caused by Myocardial Ischemia-Reperfusion in the Anesthetized Rat J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 380 - 387. [Abstract] [Full Text]
|
|
|
|
|
|
A. Lochner, E. Marais, S. Genade, and J. A. Moolman Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2752 - H2765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Tanhehco, K. Yasojima, P. L. McGeer, E. G. McGeer, and B. R. Lucchesi Preconditioning reduces myocardial complement gene expression in vivo Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1157 - H1165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tong, W. Chen, C. Steenbergen, and E. Murphy Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C Circ. Res., August 18, 2000; 87(4): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Kudej, S.-J. Kim, Y.-T. Shen, J. B. Jackson, A. B. Kudej, G.-P. Yang, S. P. Bishop, and S. F. Vatner Nitric oxide, an important regulator of perfusion-contraction matching in conscious pigs Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H451 - H456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kanno, P. C. Lee, Y. Zhang, C. Ho, B. P. Griffith, L. L. Shears II, and T. R. Billiar Attenuation of Myocardial Ischemia/Reperfusion Injury by Superinduction of Inducible Nitric Oxide Synthase Circulation, June 13, 2000; 101(23): 2742 - 2748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sasaki, T. Sato, A. Ohler, B. O’Rourke, and E. Marban Activation of Mitochondrial ATP-Dependent Potassium Channels by Nitric Oxide Circulation, February 1, 2000; 101(4): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. L. Ma, F. Gao, G.-L. Liu, B. L. Lopez, T. A. Christopher, J. M. Fukuto, D. A. Wink, and M. Feelisch Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury PNAS, December 7, 1999; 96(25): 14617 - 14622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinmura, X.-L. Tang, H. Takano, M. Hill, and R. Bolli Nitric oxide donors attenuate myocardial stunning in conscious rabbits Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2495 - H2503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Csonka, Z. Szilvassy, F. Fulop, T. Pali, I. E. Blasig, A. Tosaki, R. Schulz, and P. Ferdinandy Classic Preconditioning Decreases the Harmful Accumulation of Nitric Oxide During Ischemia and Reperfusion in Rat Hearts Circulation, November 30, 1999; 100(22): 2260 - 2266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Jordan, Z.-Q. Zhao, and J. Vinten-Johansen The role of neutrophils in myocardial ischemia-reperfusion injury Cardiovasc Res, September 1, 1999; 43(4): 860 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovasc Res, August 15, 1999; 43(3): 698 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Bing, T. Yamamoto, M. Yamamoto, R. Kakar, and A. Cohen New look at myocardial infarction: toward a better aspirin Cardiovasc Res, July 1, 1999; 43(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Jones, W. G. Girod, A. J. Palazzo, D. N. Granger, M. B. Grisham, D. Jourd'Heuil, P. L. Huang, and D. J. Lefer Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1567 - H1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Agullo, D. Garcia-Dorado, J. Inserte, A. Paniagua, P. Pyrhonen, J. Llevadot, and J. Soler-Soler L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1574 - H1580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Mori, N. Haramaki, H. Ikeda, and T. Imaizumi Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs Cardiovasc Res, October 1, 1998; 40(1): 113 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takano, S. Manchikalapudi, X.-L. Tang, Y. Qiu, A. Rizvi, A. K. Jadoon, Q. Zhang, and R. Bolli Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits Circulation, August 4, 1998; 98(5): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Weinbrenner, G. S Liu, J. M Downey, and M. V Cohen Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia Cardiovasc Res, June 1, 1998; 38(3): 676 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Delaney, P. N. Shepel, and J. D. Geiger Levels of Endogenous Adenosine in Rat Striatum. I. Regulation by Ionotropic Glutamate Receptors, Nitric Oxide and Free Radicals J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 561 - 567. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Ishibashi, D. J. Duncker, J. Zhang, and R. J. Bache ATP-Sensitive K+ Channels, Adenosine, and Nitric Oxide–Mediated Mechanisms Account for Coronary Vasodilation During Exercise Circ. Res., February 23, 1998; 82(3): 346 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor Circulation, January 27, 1998; 97(3): 276 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qiu, A. Rizvi, X.-L. Tang, S. Manchikalapudi, H. Takano, A. K. Jadoon, W.-J. Wu, and R. Bolli Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2931 - H2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. O. Nossuli, R. Hayward, R. Scalia, and A. M. Lefer Peroxynitrite Reduces Myocardial Infarct Size and Preserves Coronary Endothelium After Ischemia and Reperfusion in Cats Circulation, October 7, 1997; 96(7): 2317 - 2324. [Abstract] [Full Text]
|
|
|
|
|
|
T. Minamino, M. Kitakaze, K. Node, H. Funaya, and M. Hori Inhibition of Nitric Oxide Synthesis Increases Adenosine Production via an Extracellular Pathway Through Activation of Protein Kinase C Circulation, September 2, 1997; 96(5): 1586 - 1592. [Abstract] [Full Text]
|
|
|
|
|
|
R. Bolli, Z. A. Bhatti, X.-L. Tang, Y. Qiu, Q. Zhang, Y. Guo, and A. K. Jadoon Evidence That Late Preconditioning Against Myocardial Stunning in Conscious Rabbits Is Triggered by the Generation of Nitric Oxide Circ. Res., July 19, 1997; 81(1): 42 - 52. [Abstract] [Full Text]
|
|